| Mechanisms of multidrug resistance in cancer JP Gillet, MM Gottesman Multi-drug resistance in cancer, 47-76, 2010 | 889 | 2010 |
| The clinical relevance of cancer cell lines JP Gillet, S Varma, MM Gottesman Journal of the National Cancer Institute 105 (7), 452-458, 2013 | 777 | 2013 |
| Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance JP Gillet, AM Calcagno, S Varma, M Marino, LJ Green, MI Vora, C Patel, ... Proceedings of the National Academy of Sciences 108 (46), 18708-18713, 2011 | 601 | 2011 |
| Chemotherapy-induced resistance by ATP-binding cassette transporter genes JP Gillet, T Efferth, J Remacle Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1775 (2), 237-262, 2007 | 474 | 2007 |
| Toward a better understanding of the complexity of cancer drug resistance MM Gottesman, O Lavi, MD Hall, JP Gillet Annual review of pharmacology and toxicology 56 (1), 85-102, 2016 | 352 | 2016 |
| Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics AM Calcagno, CD Salcido, JP Gillet, CP Wu, JM Fostel, MD Mumau, ... Journal of the National Cancer Institute 102 (21), 1637-1652, 2010 | 339 | 2010 |
| Drug resistance: still a daunting challenge to the successful treatment of AML BC Shaffer, JP Gillet, C Patel, MR Baer, SE Bates, MM Gottesman Drug Resistance Updates 15 (1-2), 62-69, 2012 | 308 | 2012 |
| Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes JP Gillet, T Efferth, D Steinbach, J Hamels, F De Longueville, V Bertholet, ... Cancer research 64 (24), 8987-8993, 2004 | 285 | 2004 |
| Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma KG Chen, JC Valencia, JP Gillet, VJ Hearing, MM Gottesman Pigment cell & melanoma research 22 (6), 740-749, 2009 | 229 | 2009 |
| ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia D Steinbach, JP Gillet, A Sauerbrey, B Gruhn, K Dawczynski, V Bertholet, ... Clinical cancer research 12 (14), 4357-4363, 2006 | 177 | 2006 |
| Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein B Stordal, M Hamon, V McEneaney, S Roche, JP Gillet, JJ O’Leary, ... PloS one 7 (7), e40717, 2012 | 111 | 2012 |
| MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor AR Chakraborty, RW Robey, VL Luchenko, Z Zhan, RL Piekarz, JP Gillet, ... Blood, The Journal of the American Society of Hematology 121 (20), 4115-4125, 2013 | 93 | 2013 |
| Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer JP Gillet, M M Gottesman Current pharmaceutical biotechnology 12 (4), 686-692, 2011 | 91 | 2011 |
| A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration R Van De Ven, GL Scheffer, AW Reurs, JJ Lindenberg, R Oerlemans, ... Blood, The Journal of the American Society of Hematology 112 (6), 2353-2359, 2008 | 85 | 2008 |
| Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia T Efferth, JP Gillet, A Sauerbrey, F Zintl, V Bertholet, F de Longueville, ... Molecular cancer therapeutics 5 (8), 1986-1994, 2006 | 82 | 2006 |
| Multidrug resistance–linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma JP Gillet, AM Calcagno, S Varma, B Davidson, M Bunkholt Elstrand, ... Clinical Cancer Research 18 (11), 3197-3206, 2012 | 69 | 2012 |
| LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes L Homolya, D Fu, P Sengupta, M Jarnik, JP Gillet, L Vitale-Cross, ... PloS one 9 (3), e91921, 2014 | 63 | 2014 |
| Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors S Rottenberg, MA Vollebergh, B de Hoon, J de Ronde, PC Schouten, ... Cancer research 72 (9), 2350-2361, 2012 | 62 | 2012 |
| The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer JP Gillet, B Macadangdang, RL Fathke, MM Gottesman, C Kimchi-Sarfaty Gene Therapy of Cancer: Methods and Protocols, 5-54, 2009 | 62 | 2009 |
| Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity C Patel, L Stenke, S Varma, ML Lindberg, M Björkholm, J Sjöberg, ... Cancer 119 (16), 3076-3083, 2013 | 57 | 2013 |
